Numerous studies have reported increases in asthma prevalence among children world-wide. Less is known about similar trends in adults. We aimed to investigate whether the prevalence of allergic asthma symptoms had increased in an adult general population.
Introduction
There is evidence that the prevalence of asthma has increased in children in many countries (1) (2) (3) (4) . Less is known about similar trends in adult populations (5) . It has not yet been possible to develop a simple objective diagnostic test for asthma (6) , and most studies of trends of asthma prevalence have defined asthma as self-reported diagnosed asthma or self-reported asthma symptoms (7) . However, concurrent with the reported increases in asthma prevalence the recognition of asthma is likely to have increased as well (1, 2, 3, 9) . This would tend to over-estimate increases in asthma prevalence when self-reported diagnosed asthma is used in time trend studies. Assessment of asthma symptoms may not to the same degree be susceptible to changes in the labelling of asthma (5) , and questionnaires on asthma symptoms therefore remain the cornerstone of large-scale epidemiological studies (10) . Nevertheless, the awareness of asthma symptoms may also change over time, and it would therefore be appropriate to validate asthma symptom questionnaires in relation to objective measures.
The aim of the present study was to investigate whether the prevalence of allergic asthma symptoms had increased in an adult general population over a 9-year period. The questionnaire employed was validated in relation to specific immunoglobulin E (IgE) positivity at both cross-sectional surveys in the beginning and at the end of the period. We also investigated the association between rhinitis and asthma related to exposure to the same group of allergens.
Methods

SUBJECTS AND DESIGN
This study is based on two cross-sectional surveys in 1989 and 1998 using the same sampling frame and method. An identical one-page questionnaire on respiratory symptoms was mailed to random samples of 15-41-year-olds living in the western part of Copenhagen County (Denmark), which is an urban area with a high prevalence of self-reported asthma compared to rural areas in Denmark (11) . Citizenship (Danish) and birthplace (Denmark) further restricted the samples. In both surveys, the questionnaire was mailed in November (autumn; out of the pollen season) and followed, if necessary, by two reminders.
QUESTIONNAIRE AND DEFINITIONS
The questionnaire comprised questions on upper and lower airway symptoms on exposure to three different groups of aeroallergens: pollen, animal dander and dust mite (questions b and f; c and g; d and h in Table 1 ). In addition, questions on lower airway symptoms considered nonallergic in nature were included (questions e and i-k in Table 1 ).
Based on symptoms reported in the questionnaire the following 'diagnoses' of allergic rhinitis and allergic asthma were defined: 'rhinitis related to pollen exposure ('yes' to question b) and 'asthma related to pollen exposure' ('yes' to question f); 'rhinitis related to dander exposure' ('yes' to question c) and 'asthma related to dander exposure' ('yes' to question g); 'rhinitis related to mite exposure' ('yes' to question d) and 'asthma related to mite exposure' ('yes' to question h). Furthermore, for the above diagnoses of allergic asthma the corresponding 12-month period prevalences were defined by combining these symptoms with symptom e ('shortness of breath when at rest at any time in last 12 months'). For example, if the answers to question e and question f were both 'yes', 'asthma related to pollen exposure' was considered present within the last 12 months.
VALIDATION OF THE QUESTIONNAIRE IN 1990 AND 1998
The questionnaire was validated in relation to specific IgE positivity to common aeroallergens in a random sample of responders to the questionnaire in connection with both surveys. The study populations and methods have previously been described in more detail (12) . Briefly, in 1990 and 1998, random samples of 312 and 482 responders to the questionnaire participated in a health examination including blood sample drawing. Serum samples from the participants were analysed for specific IgE to birch, grass, mugwort, dog and cat dander, and house dust mite (D. pteronyssinus) using the ADVIA 1 Centaur TM Specific IgE assay system (Bayer Corporation). The analysis for specific IgE was judged to be positive if the measurement of specific IgE was in excess of 0?35 kU l 71 .
Sensitivity was defined as the proportion of subjects reporting a given symptom among all those with a positive test for specific IgE to the relevant allergen(s). Specificity was defined as the proportion of subjects without a given symptom among those with a negative test for specific IgE to the relevant allergen(s). The positive predictive value was defined as the proportion of subjects specific-IgE-positive to relevant allergen(s) among those reporting a given symptom.
STATISTICAL ANALYSIS
Three age groups were defined: 15-23 years, 24-32 years and 33-41 years. The changes in the prevalence of symptoms were expressed by odds ratios comparing the second to the first survey. The odds ratios were adjusted for differences in the distribution on sex and age group in a logistic regression model. Test for homogeneity of the odds ratios by age group (or sex) was done by testing for interaction between survey and age group (or sex). All data were analysed using the Statistical Products and Service Solutions package (SPSS) for Windows (Release 8.0).
Results
The response rates were 86?6% (3624/4185) and 78?8% (2402/3048) in 1989 and 1998, respectively. In both surveys, the prevalence of missing answers was less than 1?4% for all questions. The prevalence of 'asthma related to pollen exposure', 'asthma related to dander exposure', and 'asthma related to mite exposure' increased significantly (symptoms f-h in Table 1 ). In contrast, the prevalence of lower airway symptoms of a more general nature, i.e. nonallergic, were virtually unchanged (symptoms e and i-k in Table 1 ). In addition, 'rhinitis related to pollen exposure' 'rhinitis related to dander exposure', and 'rhinitis related to mite exposure' showed very similar and significant increases (symptoms b-d in Table 1 ). Among the symptoms that increased significantly, 'rhinitis related to dander exposure', 'rhinitis related to mite exposure' and 'asthma related to mite exposure' increased significantly more among males than among females. The prevalence of these symptoms were significantly lower among men in the first survey, but these differences thus diminished in the second survey. The observed increases did not show any significant trend in relation to age. Nor was this the case when data was analysed in men and women separately. Thus, allergic rhinitis and allergic asthma symptoms increased similarly in the three age groups. Table 2 shows that similar and significant increases were observed for the corresponding 12-month period prevalence of the allergic asthma symptoms.
The validation of the questions on allergic asthma symptoms with specific IgE as the reference in random samples of responders in 1990 and 1998 is shown in Table 3 . It shows that the sensitivity tended to increase, while the specificity tended to decrease, from 1990 to 1998. In contrast, the positive predictive values were reasonably stable over time. Table 4 shows the relationship between asthma and rhinitis related to exposure to the same group of allergens. Thus, the frequency of allergic asthma among subjects with allergic rhinitis was 40-50%, whereas the frequency of allergic asthma among subjects without allergic rhinitis was 1% or less. Consequently, the risk of allergic asthma among subjects with allergic rhinitis was up to 300 times that among subjects without allergic rhinitis.
Discussion
We found a significantly increased prevalence of allergic asthma symptoms in this adult general population. The previously reported increase in the prevalence of specific IgE to common aeroallergens in our background population (12) therefore appear to coincide with an increase in asthma symptoms related to allergen exposure. Furthermore, this increase is in keeping with numerous studies, mainly in children, that have reported increasing prevalences of asthma and asthma symptoms (7) . Our results suggest that in these populations increases in asthma prevalence may now also be apparent among adults.
We defined allergic asthma as a history of shortness of breath on exposure to allergens. This may not accurately reflect allergic asthma. Most trend studies of asthma symptom prevalence have employed questions on 'wheezing', which is not a commonly used phrase in Denmark. Therefore, caution should exercised when comparing the prevalence rates and increases of asthma symptoms observed in this study to those observed in other studies.
The reported increases in prevalence of asthma are likely to be due to changes in environmental or lifestyle factors (5) . If these risk factors operated in early childhood only, changes in prevalence would be apparent, at first, among the youngest subjects in our population reflecting a cohort effect. However, we observed no such age-related trend, and this may suggest that some of these risk factors operate in adulthood as well as in childhood. However, we do not know whether the age range of the study population was appropriate for detecting a possible cohort effect. { The association between the symptom and specific IgE positivity expressed as sex-and age-adjusted odds ratio. Symptom f: 'shortness of breath when near grass, trees or flowers'. Symptom g: 'shortness of breath when near furry animals'. Symptom h: 'shortness of breath when cleaning rooms or making beds, or when in bed'.
Some issues should be addressed in the interpretation of the observed increase in the prevalence of allergic asthma symptoms. Firstly, non-respondence could bias the results. The response rates were reasonably similar, although lower in the 1998 survey. Telephone interviews have previously been conducted in non-responders to the same mailed questionnaire in the same background population, and the prevalence of allergic asthma symptoms were similar among responders and non-responders (13) . Consequently, it seems unlikely that non-respondence could substantially bias the results. Secondly, the pollen seasons preceding the two surveys showed only minor differences when comparing the cumulated pollen count in Copenhagen during the 1989 and 1998 pollen seasons (14) . Thirdly, the validity, and possible changes in the validity, of the questionnaire, should be considered. The questionnaire was validated with specific IgE positivity as the reference in 1990 and again in 1998. The validation of the questions on allergic rhinitis symptoms has previously been reported (12) , and it showed that the sensitivity tended to increase, while the specificity tended to decrease from 1990 to 1998. As shown in Table 3 , this is also the case for the questions on allergic asthma symptoms. Thus, it seems that the proportion of specific IgE-positive subjects who report allergic asthma symtoms has increased, which may indicate increased awareness/ perception of symptoms or increased morbidity among specific IgE-positive subjects. In contrast, the postive predictive values of symptoms were reasonably stable over time, which may support that the observed increase in allergic asthma symptom prevalence reflects a true increase in allergic asthma prevalence. The positive predictive values are dependent on the prevalence of sensitization, which has increased in our study population from 1990 to 1998 (12) . This increase may explain that the positive predictive values were reasonably stable despite a decrease in the specificity of symptoms.
Allergic rhinitis and allergic asthma often co-exist (15) (16) (17) (18) . The similarities between allergic rhinitis and asthma outweigh the differences, and they are linked by epidemiological, histological, physiological, and immunopathological characteristics (18) . They are also linked from a therapeutic point of view. Thus, specific immunotherapy improves co-existing asthma in pollen rhinitis patients and may prevent development of asthma in children with pollen rhinitis (19, 20) , and pharmacological treatment improves co-existing asthma in allergic rhinitis patients (16) . The observed associations between rhinitis and asthma related to the same group of allergens was remarkably strong (Table 4 ). For example, 'asthma related to pollen exposure' was almost non-existent among subjects without 'rhinitis related to pollen exposure' (Table 4) , and accordingly almost 100% of subjects with 'asthma related to pollen exposure' reported 'rhinitis related to pollen exposure'. Consistent with this, it has been reported that 98?9% (360/ 364) of allergic asthmatics had rhinitis in addition (21) . These findings suggest that pollen rhinitis precedes, or develops concurrently with, pollen asthma, which lend support to the hypothesis that allergic rhinitis and allergic asthma may be manifestations of the same disease entity. The proportion of subjects with allergic rhinitis who, in addition, had allergic asthma appeared constant over time (Table 4 ). Thus, in both surveys, approximately 40% of subjects reporting 'rhinitis related to pollen exposure' also reported 'asthma related to pollen exposure', and approximately 50% of subjects reporting 'rhinitis related to dander exposure' also reported 'asthma related to dander exposure'. These findings might suggest that animal dander allergens are more likely to induce asthma than pollen allergens. In accordance with this, Plaschke et al. reported that sensitization to cat showed a stronger association with asthma and bronchial hyper-reactivity than did sensitization to grass or mite (22) . The reason for this could be that pollen allergens are relatively large and therefore less respirable.
In conclusion, we found a significantly increased prevalence of allergic asthma symptoms with no significant age related trend in this adult general population. The validity of the allergic asthma symptoms in relation to specific IgE positivity also changed over time, and some caution should therefore be exercised in the interpretion of the results. However, the finding that the positive predictive values were reasonably stable over time, may support that the increased prevalence of allergic asthma symptoms reflects a true increase in allergic asthma. Considering these results, we fear that asthma continues to increase, and that this increase is not limited to children in affected populations.
